Stockscreener 앱 받기
1.80
4.26%
-0.08
시간 외 거래:
1.85
0.05
+2.78%
Humacyte Inc 주식(HUMA)의 최신 뉴스
Humacyte Requests to Dismiss Class Action Filed by Investors - TradingView
Will Humacyte Inc. stock hit new highs in YEARNew Guidance & Daily Profit Focused Screening - thegnnews.com
Investors Hope for Bounce in Humacyte Inc. Equity Warrant After SelloffQuarterly Profit Review & Weekly Watchlist for Hot Stocks - metal.it
Humacyte Inc. Hits Oversold Level on RSI IndicatorAI Driven Entry Signal Forecast - beatles.ru
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. LawsuitHUMA - ACCESS Newswire
Humacyte Inc. Equity Warrant’s volatility index tracking explainedJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Risk adjusted return profile for Humacyte Inc. analyzedWeekly Stock Recap & Target Return Focused Picks - Newser
Detecting price anomalies in Humacyte Inc. Equity Warrant with AIJuly 2025 Setups & High Accuracy Investment Signals - Newser
Heatmap analysis for Humacyte Inc. and competitorsJuly 2025 Reactions & Consistent Profit Trade Alerts - Newser
How to track smart money flows in Humacyte Inc.July 2025 Breakouts & Expert Verified Stock Movement Alerts - Newser
What technical models suggest about Humacyte Inc. Equity Warrant’s comeback2025 Market Outlook & Daily Profit Maximizing Trade Tips - Newser
Humacyte Inc. stock volume spike explainedJuly 2025 Review & Weekly Stock Performance Updates - Newser
Can machine learning forecast Humacyte Inc. recoveryPortfolio Return Summary & Daily Profit Focused Screening - Newser
Technical Models Suggest Humacyte Inc. Equity Warrant May Rebound SoonJuly 2025 Spike Watch & Long-Term Capital Growth Strategies - sundaytimes.kr
Humacyte Inc. Equity Warrant Could See a Relief Rally From SupportWeekly Loss Report & AI Forecast for Swing Trade Picks - beatles.ru
How to escape a deep drawdown in Humacyte Inc.Weekly Investment Report & Verified Stock Trade Ideas - Newser
How to build a custom watchlist for Humacyte Inc. Equity WarrantRate Hike & AI Enhanced Trading Alerts - Newser
Will Humacyte Inc. outperform the marketTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Is Humacyte Inc. Equity Warrant stock poised for growth2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Is Humacyte Inc. a turnaround storyQuarterly Portfolio Report & Fast Exit and Entry Trade Guides - mustnews.co.kr
Real time breakdown of Humacyte Inc. stock performance2025 Bull vs Bear & Verified Entry Point Signals - Newser
News impact scoring models applied to Humacyte Inc.Portfolio Value Summary & High Yield Stock Recommendations - Newser
Exit strategy if you’re trapped in Humacyte Inc. Equity Warrant2025 Support & Resistance & Risk Controlled Swing Alerts - Newser
Humacyte Reports Q2 2025 Earnings and Market Expansion - TipRanks
MACD Cross Could Confirm Trend in Humacyte Inc.2025 Technical Patterns & Verified Short-Term Trading Plans - newsyoung.net
Will a bounce in Humacyte Inc. Equity Warrant offer an exit2025 Year in Review & Reliable Volume Spike Trade Alerts - Newser
Will Humacyte Inc. outperform during market ralliesQuarterly Portfolio Summary & Fast Gaining Stock Reports - classian.co.kr
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors - MSN
Earnings call transcript: Humacyte Q2 2025 misses EPS and revenue targets - Investing.com Australia
Trading Bots Trigger Alerts on Humacyte Inc. ActivityJuly 2025 Recap & Free High Return Stock Watch Alerts - metal.it
A Quick Look at Today's Ratings for Humacyte(HUMA.US), With a Forecast Between $3 to $14 - 富途牛牛
Humacyte: Cash Burn And A Glacial Launch Overshadow VAC Progress (NASDAQ:HUMA) - Seeking Alpha
Humacyte stock price target lowered to $3.50 at TD Cowen on mixed outlook - Investing.com Canada
Humacyte stock rating reiterated at Buy by Benchmark despite revenue miss - Investing.com Canada
Humacyte, Inc. (NASDAQ:HUMA) Q2 2025 Earnings Call Transcript - Insider Monkey
H.C. Wainwright lowers Humacyte stock price target to $3 on weak sales - Investing.com Canada
Analysts Expect Breakeven For Humacyte, Inc. (NASDAQ:HUMA) Before Long - simplywall.st
Humacyte targets over 200 hospital access points for Symvess as VAC approvals surge and cost cuts extend cash runway - MSN
Humacyte Inc (HUMA) Q2 2025 Earnings Call Highlights: Navigating Challenges and Celebrating ... By GuruFocus - Investing.com Canada
Humacyte Inc Navigates Challenges, Celebrates Milestones in Q2 2025 Earnings Call Highlights - AInvest
Humacyte Reports Q2 Revenue Miss, Symvess Shows Progress in Hospital Access and Sales - AInvest
Humacyte Missed Revenue Forecasts But Expanded Symvess Access - Finimize
Humacyte Posts Q2 Revenue Miss - AOL.com
Humacyte: D. Boral Capital Maintains Buy, PT Raised to $25 from $20. - AInvest
Humacyte, Inc. shares fall 31.49% intraday after reporting Q2 revenue of $301,000, far below analyst expectations of $1 million. - AInvest
Humacyte stock price target lowered to $7 at BTIG on mixed Q2 results - Investing.com Canada
Humacyte's 2025 Q2 Earnings Call: Unpacking Key Contradictions on Sales, CMS Impact, and FDA Interactions - AInvest
Sitryx gets back rights to drug from Lilly deal; Humacyte is cutting costs - Endpoints News
Humacyte Plunges 30% on Intraday Chaos: What's Fueling the Selloff? - AInvest
Humacyte Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : Humacyte, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener
Humacyte, Inc. (HUMA) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Humacyte Plunges 10.08% on Disappointing Earnings - AInvest
Assessing Humacyte's Long-Term Viability: A Cautionary Tale of Recurring Losses and Revenue Shortfalls - AInvest
Humacyte earnings missed by $0.08, revenue fell short of estimates - Investing.com Canada
Humacyte Posts Q2 Revenue Miss - The Motley Fool
Is this a good reentry point in Humacyte Inc. Equity WarrantFree Breakout Entry Signal Confirmation Tool - Newser
Humacyte misses Q2 revenue estimates, net loss narrows - MarketScreener
Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Humacyte Q2 Earnings: Military Hospitals Join 277-Strong Network as Product Sales Hit Record High - Stock Titan
Is Humacyte Inc. forming a double bottomBottom Formation Alert - mustnews.co.kr
Humacyte Q2 2025 Earnings Call Transcript - MarketBeat
Humacyte WRT HUMAW 2025Q2 Earnings Preview Upside Potential Driven by Innovative Product Pipeline - AInvest
Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 - The Manila Times
Humacyte Q2 FY23: Revenue $11.1mln, down 23% YoY. - AInvest
Humacyte Q2 Earnings: Bioengineered Tissue Pioneer Reveals Latest Financial Performance - Stock Titan
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
1.18%
자본화:
|
볼륨(24시간):